Relationship Between Laboratory-Measured HbA1c and Continuous Glucose Monitoring-Derived Glucose Management Indicator in Adults With Cystic Fibrosis-Related Diabetes.

Read full text
Authors: Nithya Kadiyala, Amanda L. Brennan, Alistair N. Lumb, Richard IG Holt, D. Lau, Parag Yajnik, Yee Seun Cheah, Shahideh Safavi, Imogen C. Felton, Gordon MacGregor, Andrew Clayton, A. M. Nugent
+4 more Laura Barlow, Amanda Adler, Roman Hovorka, Charlotte K. Boughton
Cited by: 0

Abstract

Cystic Fibrosis (CF) diabetes is characterised by progressive destruction of beta-cells, dysfunctional and inadequate insulin secretion, and fluctuating insulin resistance. Introduction of cystic fibrosis transmembrane conductance regulator (CFTR) modulators has led to people with CF living longer and healthier lives. Non-pulmonary complications, including CF diabetes, have become increasingly common and burdensome.

Fields of Study & Subjects

Diabetes Management and Research Cystic Fibrosis Research Advances Diabetes Treatment and Management

Publication details

Journal / source
Apollo (University of Cambridge)
Publication date
10 January 2026
Language
EN